CXCR2: From bench to bedside

Frontiers in Immunology

Volumn 3, Issue AUG, 2012, Pages

  Stadtmann, Anika ^a,b   Zarbock, Alexander ^a,b  

^a University of M nster   (Germany)

^b Max Planck Institute M nster   (Germany)

Author keywords

Chemokine receptor; CXCR2; G i Signaling

Indexed keywords

EID: 84872484656     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00263     Document Type: Article

References (155)

1. Abonia, J. P., Austen, K. F., Rollins, B. J., Joshi, S. K., Flavell, R. A., Kuziel, W. A., Koni, P. A., and Gurish, M. F. (2005). Constitutive homing of mast cell progenitors to the intestine depends on autologous expression of the chemokine receptor CXCR2. Blood 105, 4308-4313.
2. Abram, C. L., and Lowell, C. A. (2007). Convergence of immunoreceptor and integrin signaling. Immunol. Rev. 218, 29tdthom#x2013;44.
3. Addison, C. L., Daniel, T. O., Bur-dick, M. D., Liu, H., Ehlert, J. E., Xue, Y. Y., Buechi, L., Walz, A., Richmond, A., and Strieter, R. M. (2000). The CXC chemokine recep-tor 2, CXCR2,is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. J. Immunol. 165, 5269-;5277.
4. Aggarwal, A., Baker, C. S., Evans, T. W., and Haslam, P. L. (2000). G-CSF and IL-8 but not GM-CSF cor-relate with severity of pulmonary neutrophilia in acute respiratory dis-tress syndrome. Eur. Respir. J. 15, 895-901.
5. Andaluz-Ojeda, D., Iglesias, V., Bobillo, F., Almansa, R., Rico, L., Gan-dia, F., Loma, A. M., Nieto, C., Diego, R., Ramos, E., Nocito, M., Resino, S., Eiros, J. M., Tamayo, E., de Lejarazu, R. O., and Bermejo-Martin, J. F. (2011). Early natural killer cell counts in blood predict mortality in severe sepsis. Crit. Care 15, R243.
6. Babu, A. N., Murakawa, T., Thurman, J. M., Miller, E. J., Henson, P. M., Zamora, M. R., Voelkel, N. F., and Nicolls, M. R. (2007). Microvascular destruction identifies murine allo-grafts that cannot be rescued from airway fibrosis. J. Clin. Invest. 117, 3774-3785.
7. Baggiolini, M. (1998). Chemokines and leukocyte traffic. Nature 392, 565-568.
8. Baggiolini, M., Dewald, B., and Moser, B. (1994). Interleukin-8 and related chemotactic cytokines tdthom#x2013; CXC and CC chemokines. Adv. Immunol. 55, 97-179.
9. Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A., and Schall, T. J. (1997). A new class of membrane-bound chemokine with a CX3C motif. Nature 385, 640-644.
10. Belperio, J. A., Keane, M. P., Arenberg, D. A., Addison, C. L., Ehlert, J. E., Burdick, M. D., and Strieter, R. M. (2000). CXC chemokines in angiogenesis. J. Leukoc. Biol. 68, 1tdthom#x2013;8.
11. Belperio, J. A., Keane, M. P., Burdick, M. D., Gomperts, B. N., Xue, Y. Y., Hong, K., Mestas, J., Zisman, D., Ardehali, A., Saggar, R., Lynch, J. P. III, Ross, D. J., and Stri-eter, R. M. (2005). CXCR2/CXCR2 ligand biology during lung trans-plant ischemia-reperfusion injury. J. Immunol. 175, 6931-6939.
12. Berridge, M. J., and Irvine, R. F. (1984). Inositol trisphosphate, a novel sec-ond messenger in cellular signal transduction. Nature 312, 315-321
13. Bertini, R., Allegretti, M., Bizzarri, C., Moriconi, A., Locati, M., Zampella, G., Cervellera, M. N., Di Cioccio, V., Cesta, M. C., Galliera, E., Mar-tinez, F. O., Di Bitondo, R., Troiani, G., Sabbatini, V., DAnniballe, G., Anacardio, R., Cutrin, J. C., Cav-alieri, B., Mainiero, F., Strippoli, R., Villa, P., Di Girolamo, M., Martin, F., Gentile, M., Santoni, A., Corda, D., Poli, G., Manto-vani, A., Ghezzi, P., and Colotta, F. (2004). Noncompetitive non-competitive allosteric inhibitors of the inflammatory chemokine recep-tors CXCR1 and CXCR2: preven-tion of reperfusion injury. Proc. Natl. Acad. Sci. U.S.A. 101, 1179-1796
14. Bizzarri, C., Beccari, A. R., Bertini, R., Cavicchia, M. R., Giorgini, S., and Allegretti, M. (2006). ELR+ CXC chemokines and their recep-tors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets. Pharmacol. Ther. 112, 139tdthom#x2013;149.
15. Bizzarri, C., Pagliei, S., Brandolini, L., Mascagni, P., Caselli, G., Transidico, P., Sozzani, S., and Bertini, R. (2001). Selective inhibition of interleukin-8-induced neutrophil chemotaxis by ketoprofen isomers. Biochem. Pharmacol. 61, 1429tdthom#x2013;1437.
16. Block, H., Herter, J. M., Rossaint, J., Stadtmann, A., Kliche, S., Lowell, C. A., and Zarbock, A. (2012). Crucial role of SLP-76 and ADAP for neu-trophil recruitment in mouse kidney ischemia-reperfusion injury. J. Exp. Med. 209, 407-421.
17. Bousquet, J., Jeffery, P. K., Busse, W. W., Johnson, M., and Vignola, A. M. (2000). Asthma From bronchocon-striction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 161, 1720-;1745.
18. Boyle, E. M. Jr., Kovacich, J. C., Hebert, C. A., Canty, T. G. Jr., Chi, E., Morgan, E. N., Pohlman, T. H., and Verrier, E. D. (1998). Inhibition of interleukin-8 blocks myocardial ischemia-reperfusion injury. J. Tho-rac. Cardiovasc. Surg. 116, 114tdthom#x2013;121
19. Burns, J. M., Summers, B. C., Wang, Y., Melikian, A., Berahovich, R., Miao, Z., Penfold, M. E., Sunshine, M. J., Littman, D. R., Kuo, C. J., Wei, K., McMaster, B. E., Wright, K., Howard, M. C., and Schall, T. J. (2006). A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor develop-ment. J. Exp. Med. 203, 2201-2213.
20. Camps, M., Carozzi, A., Schnabel, P., Scheer, A., Parker, P. J., and Gierschik, P. (1992). Isozyme-selective stimu-lation of phospholipase C-beta 2 by G protein beta gamma-subunits. Nature 360, 684-686.
21. Chapman, R. W., Minnicozzi, M., Celly, C. S., Phillips, J. E., Kung, T. T., Hipkin, R. W., Fan, X., Rindgen, D., Deno, G., Bond, R., Gonsiorek, W., Billah, M. M., Fine, J. S., and Hey, J. A. (2007). A novel, orally active CXCR1/2 receptor antago-nist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflamma-tion. J. Pharmacol. Exp. Ther. 322, 486-;493.
22. Chapman, R. W., Phillips, J. E., Hipkin, R. W., Curran, A. K., Lundell, D., and Fine, J. S. (2009). CXCR2 antagonists for the treatment of pulmonary disease. Pharmacol. Ther. 121, 55tdthom#x2013;68.
23. Clunes, M. T., and Boucher, R. C. (2007). Cystic fibrosis: the mecha-nisms of pathogenesis of an inher-ited lung disorder. Drug Discov. Today Dis. Mech. 4, 63tdthom#x2013;72.
24. Coelho, F. M., Pessini, A. C., Coelho, A. M., Pinho, V. S., Souza, D. G., Arantes, E. C., Teixeira, M. M., and Teixeira, A. L. (2007). Platelet acti-vating factor receptors drive CXC chemokine production, neutrophil influx and edema formation in the lungs of mice injected with Tityus serrulatus venom. Toxicon 50, 420tdthom#x2013;427.
25. Craig, A., Mai, J., Cai, S., and Jeyasee-lan, S. (2009). Neutrophil recruit-ment to the lungs during bacter-ial pneumonia. Infect. Immun. 77, 568-;575.
26. Cugini, D., Azzollini, N., Gagliardini, E., Cassis, P., Bertini, R., Colotta, F., Noris, M., Remuzzi, G., and Benigni, A. (2005). Inhibition of the chemokine receptor CXCR2 pre-vents kidney graft function deterio-ration due to ischemia/reperfusion. Kidney Int. 67, 1753-1761.
27. Cummings, C. J., Martin, T. R., Fre-vert, C. W., Quan, J. M., Wong, V. A., Mongovin, S. M., Hagen, T. R., Steinberg, K. P., and Goodman, R. B. (1999). Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis. J. Immunol. 162, 2341-2346.
28. Cunha, T. M., Barsante, M. M., Guer-rero, A. T., Verri, W. A. Jr., Ferreira, S. H., Coelho, F. M., Bertini, R., Di, G. C., Allegretti, M., Cunha, F. Q., and Teixeira, M. M. (2008). Treatment with DF 2162, a non-competitive allosteric inhibitor of CXCR1/2, diminishes neutrophil influx and inflammatory hypernociception in mice. Br. J. Pharmacol. 154,460-;470
29. de Boer, W. I. (2002). Cytokines and therapy in COPD: a promising com-bination? Chest 121, 209-218S.
30. de Boer, W. I., Sont, J. K.,van, S.A., Stolk, J., van Krieken, J. H., and Hiemstra, P. S. (2000). Monocyte chemoat-tractant protein 1, interleukin 8, and chronic airways inflammation in COPD. J. Pathol. 190, 619-626.
31. Dean, T. P., Dai, Y., Shute, J. K., Church, M. K., and Warner, J. O. (1993). Interleukin-8 concentra-tions are elevated in bronchoalveolar lavage, sputum, and sera of children with cystic fibrosis. Pediatr. Res. 34, 159tdthom#x2013;161.
32. Del, R. L., Bennouna, S., Salinas, J., and Denkers, E. Y. (2001). CXCR2 deficiency confers impaired neu-trophil recruitment and increased susceptibility during Toxoplasma gondii infection. J. Immunol. 167, 6503tdthom#x2013;6509.
33. Dombrovskiy, V. Y., Martin, A. A., Sun-derram, J., and Paz, H. L. (2007). Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit. Care Med. 35, 1244-1250.
34. Eash, K. J., Greenbaum, A. M., Gopalan, P. K., and Link, D. C. (2010). CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. J. Clin. Invest. 120, 2423-2431.
35. Elizur, A., Cannon, C. L., and Ferkol, T. W. (2008). Airway inflam-mation in cystic fibrosis. Chest 133, 489tdthom#x2013;495.
36. Eltzschig, H. K., and Eckle, T. (2011). Ischemia and reperfusion from mechanism to translation. Nat. Med. 17, 1391-;1401.
37. Etzioni, A. (2010). Defects in the leuko-cyte adhesion cascade. Clin. Rev. Allergy Immunol. 38, 54-60.
38. Feniger-Barish, R., Yron, I., Meshel, T., Matityahu, E., and Ben-Baruch, A. (2003). IL-8-induced migra-tory responses through CXCR1 and CXCR2: association with phospho-rylation and cellular redistribution of focal adhesion kinase. Biochem-istry 42, 2874-2886.
39. Fu, W., Zhang, Y., Zhang, J., and Chen, W. F. (2005). Cloning and charac-terization of mouse homolog of the CXC chemokine receptor CXCR1. Cytokine 31, 9-17.
40. Fudala, R., Krupa, A., Matthay, M. A., Allen, T. C., and Kurdowska, A. K. (2007). Anti-IL-8 autoantibody: IL-8 immune complexes suppress spon-taneous apoptosis of neutrophils. Am. J. Physiol. Lung Cell Mol. Physiol. 293, L364tdthom#x2013;L374.
41. Fujimura, M., Myou, S., Nomura, M., Mizuguchi, M., Matsuda, T., Harada, A., Mukaida, N., Matsushima, K., and NonomuraNon-omura, A. (1999). Interleukin-8 inhalation directly provokes bron-choconstriction in guinea pigs. Allergy 54, 386-391.
42. Fumagalli, L., Zhang, H., Baruzzi, A., Lowell, C. A., and Berton, G. (2007). The Src family kinases Hck and Fgr regulate neutrophil responses to N-formyl-methionyl-leucyl-phenylalanine. J. Immunol. 178, 3874-2013;3885.
43. Gakidis, M. A., Cullere, X., Olson, T., Wilsbacher, J. L., Zhang, B., Moores, S. L., Ley, K., Swat, W., Mayadas, T., and Brugge, J. S. (2004). Vav GEFs are required for beta2 integrin-dependent functions of neutrophils. J. Cell Biol. 166, 273-2013;282.
44. Garau, A., Bertini, R., Colotta, F., Casilli, F., Bigini, P., Cagnotto, A., Men-nini, T., Ghezzi, P., and Villa, P. (2005). Neuroprotection with the CXCL8 inhibitor repertaxin in tran-sient brain ischemia. Cytokine 30, 125-131.
45. Geiser, T., Dewald, B., Ehrengruber, M. U., Clark-Lewis, I., and Baggiolini, M. (1993). The interleukin-8-related chemotactic cytokines GRO alpha, GRO beta, and GRO gamma acti-vate human neutrophil and basophil leukocytes. J. Biol. Chem. 268, 15419tdthom#x2013;15424.
46. Ghosh, P., Garcia-Marcos, M., Born-heimer, S. J., and Farquhar, M. G. (2008). Activation of Galphai3 triggers cell migration via regu-lation of GIV. J. Cell Biol. 182, 381tdthom#x2013;393.
47. Giagulli, C., Ottoboni, L., Caveggion, E., Rossi, B., Lowell, C., Constan-tin, G., Laudanna, C., and Berton, G. (2006). The Src family kinases Hck and Fgr are dispensable for inside-out, chemoattractant-induced sig-naling regulating beta 2 inte-grin affinity and valency in neu-trophils, but are required for beta 2 integrin-mediated outside-in signal-ing involved in sustained adhesion. J. Immunol. 177, 604-611.
48. Glogauer, M., Marchal, C. C., Zhu, F., Worku, A., Clausen, B. E., Foerster, I., Marks, P., Downey, G. P., Dinauer, M., and Kwiatkowski, D. J. (2003). Rac1 deletion in mouse neu-trophils has selective effects on neu-trophil functions. J. Immunol. 170, 5652;5657.
49. Goldstein, W., and Doring, G. (1986). Lysosomal enzymes from polymor-phonuclear leukocytes and pro-teinase inhibitors in patients with cystic fibrosis. Am. Rev. Respir. Dis. 134, 49tdthom#x2013;56.
50. Govindaraju, V., Michoud, M. C., Al-Chalabi, M., Ferraro, P., Powell, W. S., and Martin, J. G. (2006). Interleukin-8: novel roles in human airway smooth muscle cell contrac-tion and migration. Am. J. Physiol. Cell Physiol. 291, C957tdthom#x2013;C965.
51. Gu, Y., Filippi, M. D., Cancelas, J. A., Siefring, J. E., Williams, E. P., Jasti, A. C., Harris, C. E., Lee, A. W., Prabhakar, R., Atkinson, S. J., Kwiatkowski, D. J., and Williams, D. A. (2003). Hematopoietic cell reg-ulation by Rac1 and Rac2 guano-sine triphosphatases. Science 302, 445-449.
52. Hallgren, J., Jones, T. G., Abonia, J. P., Xing, W., Humbles, A., Austen, K. F., and Gurish, M. F. (2007). Pul-monary CXCR2 regulates VCAM-1 and antigen-induced recruitment of mast cell progenitors. Proc. Natl. Acad. Sci. U.S.A. 104, 20478-20483
53. Hartl, D., Latzin, P., Hordijk, P., Mar-cos, V., Rudolph, C., Woischnik, M., Krauss-Etschmann, S., Koller, B., Reinhardt, D., Roscher, A. A., Roos, D., and Griese, M. (2007). Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat. Med. 13, 1423-1430.
54. Hashimoto, M., Tanaka, H., and Abe, S. (2005). Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD. Chest 127, 965tdthom#x2013;972.
55. Henson, P. M., and Johnston, R. B. Jr. (1987). Tissue injury in inflam-mation. Oxidants, proteinases, and cationic proteins. J. Clin. Invest. 79, 669-674.
56. Hildebrand, F., Stuhrmann, M., van Griensven, M., Meier, S., Hasenkamp, S., Krettek, C., and Pape, H. C. (2007). Association of IL-8-251A/T polymorphism with incidence of acute respiratory distress syndrome (ARDS) and IL-8 synthesis after multiple trauma. Cytokine 37, 192-199.
57. Hillyer, P., Mordelet, E., Flynn, G., and Male, D. (2003). Chemokines, chemokine receptors and adhesion molecules on different human endothelia: discriminating the tissue-specific functions that affect leucocyte migration. Clin. Exp. Immunol. 134, 431tdthom#x2013;441.
58. Hirsch, E., Katanaev, V. L., Gar-landa, C., Azzolino, O., Pirola, L., Silengo, L., Sozzani, S., Mantovani, A., Altruda, F., and Wymann, M. P. (2000). Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 287, 1049tdthom#x2013;1053.
59. Hogg, J. C., Chu, F., Utokaparch, S., Woods, R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., and Pare, P. D. (2004). The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 350, 2645-2653.
60. Holz, O., Khalilieh, S., Ludwig-Sengpiel, A., Watz, H., Stryszak, P., Soni, P., Tsai, M., Sadeh, J., and Magnussen, H. (2010). SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy sub-jects. Eur. Respir. J. 35, 564-;570.
61. Hyduk, S. J., Chan, J. R., Duffy, S. T., Chen, M., Peterson, M. D., Wad-dell, T. K., Digby, G. C., Szaszi, K., Kapus, A., and Cybulsky, M. I. (2007). Phospholipase C, cal-cium, and calmodulin are critical for alpha4beta1 integrin affinity up-regulation and monocyte arrest trig-gered by chemoattractants. Blood 109, 176-184.
62. Jiang, H., Kuang, Y., Wu, Y., Xie, W., Simon, M. I., and Wu, D. (1997). Roles of phospholipase C beta2 in chemoattractant-elicited responses. Proc. Natl. Acad. Sci. U.S.A. 94, 7971tdthom#x2013;7975.
63. Jiang, M., Spicher, K., Boulay, G., Martin-Requero, A., Dye, C. A., Rudolph, U., and Birnbaumer, L. (2002). Mouse gene knockout and knockin strategies in application to alpha subunits of Gi/Go family of G proteins. Meth. Enzymol. 344, 277-298.
64. Jones, S. A., Wolf, M., Qin, S., Mackay, C. R., and Baggiolini, M. (1996). Different functions for the inter-leukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxi-dase and phospholipase D are acti-vated through IL-8R1 but not IL-8R2. Proc. Natl. Acad. Sci. U.S.A. 93, 6682-6686.
65. Kaneider, N. C., Agarwal, A., Leger, A. J., and Kuliopulos, A. (2005). Reversing systemic inflammatory response syndrome with chemokine receptor pepducins. Nat. Med. 11, 661-665.
66. Keane, M. P., Belperio, J. A., Xue, Y. Y., Burdick, M. D., and Strieter, R. M. (2004). Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer. J. Immunol. 172, 2853-2860.
67. Keane, M. P., Donnelly, S. C., Belperio, J. A., Goodman, R. B., Dy, M., Bur-dick, M. D., Fishbein, M. C., and Strieter, R. M. (2002). Imbalance in the expression of CXC chemokines cor-relates with bronchoalveolar lavage fluid angiogenic activity and pro-collagen levels in acute respiratory distress syndrome. J. Immunol. 169, 6515-6521.
68. Kelner, G. S., Kennedy, J., Bacon, K. B., Kleyensteuber, S., Largaespada, D. A., Jenkins, N. A., Copeland, N. G., Bazan, J. F., Moore, K. W., and Schall, T. J. (1994). Lympho-tactin: a cytokine that represents a new class of chemokine. Science 266, 1395tdthom#x2013;1399.
69. Kempf, T., Zarbock, A., Widera, C., Butz, S., Stadtmann, A., Ros-saint, J., Bolomini-Vittori, M., Korf-Klingebiel, M., Napp, L. C., Hansen, B., Kanwischer, A., Bavendiek, U., Beutel, G., Hapke, M., Sauer, M. G., Laudanna, C., Hogg, N., Vestweber, D., and Wollert, K. C. (2011). GDF-15 is an inhibitor of leukocyte inte-grin activation required for survival after myocardial infarction in mice. Nat. Med. 17, 581-588.
70. Kim, C., and Dinauer, M. C. (2001). Rac2 is an essential regulator of neu-trophil nicotinamide adenine din-ucleotide phosphate oxidase acti-vation in response to specific sig-naling pathways. J. Immunol. 166, 1223-;1232.
71. King, R. C., Binns, O. A., Rodriguez, F., Kanithanon, R. C., Daniel, T. M., Spotnitz, W. D., Tribble, C. G., and Kron, I. L. (2000). Reperfusion injury significantly impacts clini-cal outcome after pulmonary trans-plantation. Ann. Thorac. Surg. 69, 1681tdthom#x2013;1685.
72. Kunisaki, Y., Nishikimi, A., Tanaka, Y., Takii, R., Noda, M., Inayoshi, A., Watanabe, K., Sanematsu, F., Sasazuki, T., Sasaki, T., and Fukui, Y. (2006). DOCK2 is a Rac activator that regulates motility and polarity during neutrophil chemotaxis. J. Cell Biol. 174, 647-652.
73. Kurashima, K., Mukaida, N., Fujimura, M., Schroder, J. M., Matsuda, T., and Matsushima, K. (1996). Increase of chemokine levels in sputum pre-cedes exacerbation of acute asthma attacks. J. Leukoc. Biol. 59, 313-316
74. Kurdowska, A., Carr, F. K., Stevens, M. D., Baughman, R. P., and Martin, T. R. (1997). Studies on the inter-action of IL-8 with human plasma alpha 2-macroglobulin: evidence for the presence of IL-8 complexed to alpha 2-macroglobulin in lung flu-ids of patients with adult respiratory distress syndrome. J. Immunol. 158, 1930tdthom#x2013;1940.
75. Kurdowska, A., Noble, J. M., Steinberg, K. P., Ruzinski, J. T., Hudson, L. D., and Martin, T. R. (2001). Anti-interleukin 8 autoantibody: inter-leukin 8 complexes in the acute respiratory distress syndrome. Rela-tionship between the complexes and clinical disease activity. Am. J. Respir. Crit. Care Med. 163, 463-;468.
76. Kuwano, Y., Spelten, O., Zhang, H., Ley, K., and Zarbock, A. (2010). Rolling on E-or P-selectin induces the extended but not high-affinity con-formation of LFA-1 in neutrophils. Blood 116, 617-624.
77. Lamblin, C., Gosset, P., Tillie-Leblond, I., Saulnier, F., Marquette, C. H., Wal-laert, B., and Tonnel, A. B. (1998). Bronchial neutrophilia in patients with noninfectious non-infectious status asthmaticus. Am. J. Respir. Crit. Care Med. 157, 394-402.
78. Lawson, C. D., Donald, S., Ander-son, K. E., Patton, D. T., and Welch, H. C. (2011). P-Rex1 and Vav1 cooperate in the regulation of formyl-methionyl-leucyl-phenylalanine-dependent neutrophil responses. J. Immunol. 186, 1467-;1476.
79. Lazaar, A. L., Sweeney, L. E., MacDon-ald, A. J., Alexis, N. E., Chen, C., and Tal-Singer, R. (2011). SB-656933, a novel CXCR2 selective antagonist, inhibitsexvivoneutrophilactivation and ozone-induced airway inflam-mation in humans. Br. J. Clin. Phar-macol. 72, 282-;293.
80. Ley, K., Laudanna, C., Cybulsky, M. I., and Nourshargh, S. (2007). Get-ting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7, 678-689.
81. Ley, K., and Zarbock, A. (2008). From lung injury to fibrosis. Nat. Med. 14, 20t-21.
82. L'Heureux, G. P., Bourgoin, S., Jean, N., McColl, S. R., and Naccache, P. H. (1995). Diverging signal transduction pathways activated by interleukin-8 and related chemokines in human neutrophils: interleukin-8, but not NAP-2 or GRO alpha, stimulates phos-pholipase D activity. Blood 85, 522-531.
83. Li, Z., Jiang, H., Xie, W., Zhang, Z., Smrcka, A. V., and Wu, D. (2000). Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. Sci-ence 287, 1046tdthom#x2013;1049.
84. Litt, M. R., Jeremy, R. W., Weisman, H. F., Winkelstein, J. A., and Becker, L. C. (1989). Neutrophil depletion lim-ited to reperfusion reduces myocar-dial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury. Circu-lation 80, 1816-;1827.
85. Lomas-Neira, J. L., Chung, C. S., Grutkoski, P. S., Miller, E. J., and Ayala, A. (2004). CXCR2 inhibition suppresses hemorrhage-induced priming for acute lung injury in mice. J. Leukoc. Biol. 76, 58-;64.
86. Londhe, V. A., Belperio, J. A., Keane, M. P., Burdick, M. D., Xue, Y.Y., and Stri-eter, R. M. (2005a). CXCR2 is criti-cal for dsRNA-induced lung injury: relevance to viral lung infection. J. Inflamm. (Lond.) 2, 4.
87. Londhe, V. A., Belperio, J. A., Keane, M. P., Burdick, M. D., Xue, Y.Y., and Stri-eter, R. M. (2005b). CXCR2/CXCR2 ligand biological axis impairs alve-ologenesis during dsRNA-induced lung inflammation in mice. Pediatr. Res. 58, 919tdthom#x2013;926.
88. Mackerness, K. J., Jenkins, G. R., Bush, A., and Jose, P. J. (2008). Char-acterisation of the range of neu-trophil stimulating mediators in cystic fibrosis sputum. Thorax 63, 614-620.
89. Matsuda, A., Fukuda, S., Matsumoto, K., and Saito, H. (2008). Th1/Th2 cytokines reciprocally regulate in vitro pulmonary angiogenesis via CXC chemokine synthesis. Am. J. Respir. Cell Mol. Biol. 38, 168-175.
90. Matsushima, K., Morishita, K., Yoshimura, T., Lavu, S., Kobayashi, Y., Lew, W., Appella, E., Kung, H. F., Leonard, E. J., and Oppenheim, J. J. (1988). Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J. Exp. Med. 167, 1883tdthom#x2013;1893.
91. Mayer, A. M., Brenic, S., and Glaser, K. B. (1996). Pharmacological tar-geting of signaling pathways in pro-tein kinase C-stimulated superox-ide generation in neutrophil-like HL-60 cells: effect of phorbol ester, arachidonic acid and inhibitors of kinase(s), phosphatase(s) and phos-pholipase A2. J. Pharmacol. Exp. Ther. 279, 633-644.
92. McDonald, D. M. (2001). Angiogene-sis and remodeling of airway vas-culature in chronic inflammation. Am. J. Respir. Crit. Care Med. 164, S39-S45.
93. Mei, J., Liu, Y., Dai, N., Hoffmann, C., Hudock, K. M., Zhang, P., Guttentag, S. H., Kolls, J. K., Oliver, P. M., Bushman, F. D., and Worthen, G. S. (2012). Cxcr2 and Cxcl5 regulate the IL-17/G-CSF axis and neutrophil homeostasis in mice. J. Clin. Invest. 122, 974-986.
94. Miller, A. L., Strieter, R. M., Gru-ber, A. D., Ho, S. B., and Lukacs, N. W. (2003). CXCR2 regulates respiratory syncytial virus-induced airway hyperreactivity and mucus overproduction. J. Immunol. 170, 3348-3356.
95. Moepps, B., Nuesseler, E., Braun, M., and Gierschik, P. (2006). A homolog of the human chemokine receptor CXCR1 is expressed in the mouse. Mol. Immunol. 43, 897-914.
96. Mohsenin, A., Burdick, M. D., Molina, J. G., Keane, M. P., and Black-burn, M. R. (2007). Enhanced CXCL1 production and angiogene-sis in adenosine-mediated lung dis-ease. FASEB J. 21, 1026-1036.
97. Mueller, H., Stadtmann, A., Van Aken, H., Hirsch, E., Wang, D., Ley, K., and Zarbock, A. (2010). Tyrosine kinase Btk regulates E-selectin-mediated integrin activation and neutrophil recruitment by controlling phos-pholipase C (PLC) gamma2 and PI3Kgamma pathways. Blood 115, 3118-3127.
98. Mukaida, N. (2003). Pathophysiological roles of interleukin-8/CXCL8 in pul-monary diseases.Am. J. Physiol. Lung Cell Mol. Physiol. 284, L566-L577.
99. Murdoch, C., Monk, P. N., and Finn, A. (1999). Cxc chemokine recep-tor expression on human endothelial cells. Cytokine 11, 704-712.
100. Murphy, P. M. (2002). International union of pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol. Rev. 54, 227-229.
101. Murphy, P. M., Baggiolini, M., Charo, I. F., Hebert, C. A., Horuk, R., Mat-sushima, K., Miller, L. H., Oppenheim, J. J., and Power, C. A. (2000). International union of phar-macology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52, 145-176.
102. Nasser, M. W., Raghuwanshi, S. K., Mal-loy, K. M., Gangavarapu, P., Shim, J. Y., Rajarathnam, K., and Richardson, R. M. (2007). CXCR1 and CXCR2 activation and regulation. Role of aspartate 199 of the second extra-cellular loop of CXCR2 in CXCL8-mediated rapid receptor internaliza-tion. J. Biol. Chem. 282, 6906-915
103. Ness, T. L., Hogaboam, C. M., Strieter, R. M., and Kunkel, S. L. (2003). Immunomodulatory role of CXCR2 during experimental septic peritoni-tis. J. Immunol. 171, 3775-3784.
104. Norzila, M. Z., Fakes, K., Henry, R. L., Simpson, J., and Gibson, P. G. (2000). Interleukin-8 secretion and neutrophil recruitment accom-panies induced sputum eosinophil activation in children with acute asthma.Am. J. Respir. Crit. Care Med. 161, 769tdthom#x2013;774.
105. Olson, T. S., and Ley, K. (2002). Chemokines and chemokine recep-tors in leukocyte trafficking. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283, R7-R28.
106. Palatianos, G. M., Balentine, G., Papadakis, E. G., Triantafillou, C. D., Vassili, M. I., Lidoriki, A., Dinopoulos, A., and Astras, G. M. (2004). Neutrophil depletion reduces myocardial reperfusion morbidity. Ann. Thorac. Surg. 77, 956tdthom#x2013;961.
107. Patel, L., Charlton, S. J., Chambers, J. K., and Macphee, C. H. (2001). Expression and functional analysis of chemokine receptors in human peripheral blood leukocyte popula-tions. Cytokine 14, 27-36.
108. Pease, J. E., and Sabroe, I. (2002). The role of interleukin-8 and its receptors in inflammatory lung dis-ease: implications for therapy. Am. J. Respir. Med. 1, 19-25.
109. Pebay-Peyroula, E., Rummel, G., Rosen-busch, J. P., and Landau, E. M. (1997). X-ray structure of bacteri-orhodopsin at 2.5 angstroms from microcrystals grown in lipidic cubic phases. Science 277, 1676-1681.
110. Pero, R. S., Borchers, M. T., Spicher, K., Ochkur, S. I., Sikora, L., Rao, S. P., Abdala-Valencia, H., O'Neill, K. R., Shen, H., McGarry, M. P., Lee, N. A., Cook-Mills, J. M., Sriramarao, P., Simon, M. I., Birnbaumer, L., and Lee, J. J. (2007). Galphai2-mediated signaling events in the endothelium are involved in controlling leukocyte extravasation. Proc. Natl. Acad. Sci. U.S.A. 104, 4371-4376.
111. Phillipson, M., and Kubes, P. (2011). The neutrophil in vascularinflammation. Nat. Med. 17, 1381tdthom#x2013;1390.
112. Puneet, P., Moochhala, S., and Bha-tia, M. (2005). Chemokines in acute respiratory distress syndrome. Am. J. Physiol. Lung Cell Mol. Physiol. 288, L3-L15.
113. Qiu, Y., Zhu, J., Bandi, V., Atmar, R. L., Hattotuwa, K., Guntupalli, K. K., and Jeffery, P. K. (2003). Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 168, 968-;975.
114. Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., and Zielin-ski, J. (2007). Global strategy for the diagnosis,management, and pre-vention of chronic obstructive pul-monary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 176, 532555.
115. Reutershan, J. (2006). CXCR2 the receptor to hit? Drug News Perspect. 19, 615-623.
116. Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D., and Downward, J. (1994). Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370, 527-532.
117. Rubenfeld, G. D., Caldwell, E., Peabody, E., Weaver, J., Martin, D. P., Neff, M., Stern, E. J., and Hudson, L. D. (2005). Incidence and outcomes of acute lung injury. N. Engl. J. Med. 353, 1685-1693.
118. Sato, R., Iiizumi, S., Kim, E. S., Honda, F., Lee, S. K., Adachi, N., Koyama, H., Mizutani, S., and Morio, T. (2012). Impaired cell adhesion, apopto-sis, and signaling in WASP gene-disrupted Nalm-6 pre-B cells and recovery of cell adhesion using a transducible form of WASp. Int. J. Hematol. 95, 299-310.
119. Seitz, M., Dewald, B., Gerber, N., and Baggiolini, M. (1991). Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheuma-toid arthritis. J. Clin. Invest. 87, 463-469.
120. Servant, G., Weiner, O. D., Herzmark, P., Balla, T., Sedat, J. W., and Bourne, H. R. (2000). Polarization of chemoat-tractant receptor signaling during neutrophil chemotaxis. Science 287, 1037-1040.
121. Shuster, D. E., Kehrli, M. E. Jr., and Ack-ermann, M. R. (1995). Neutrophilia in mice that lack the murine IL-8 receptor homolog. Science 269, 1590-1591.
122. Smith, D. F., Deem, T. L., Bruce, A. C., Reutershan, J., Wu, D., and Ley, K. (2006). Leuko-cyte phosphoinositide-3 kinase {gamma} is required for chemokine-induced, sustained adhesion under flow in vivo. J. Leukoc. Biol. 80, 1491-1499.
123. Souza, D. G., Bertini, R., Vieira, A. T., Cunha, F. Q., Poole, S., Allegretti, M., Colotta, F., and Teixeira, M. M. (2004). Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfu-sion injury. Br. J. Pharmacol. 143, 132-142.
124. Stadtmann, A., Brinkhaus, L., Mueller, H., Rossaint, J., Bolomini-Vittori, M., Bergmeier, W., van Aken, H., Wagner, D. D., Laudanna, C., Ley, K., and Zarbock, A. (2011). Rap1a activation by CalDAG-GEFI and p38 MAPK is involved in E-selectin-dependent slow leukocyte rolling. Eur. J. Immunol. 41, 2074-;2085.
125. Stevenson, C. S., Coote, K., Webster, R., Johnston, H., Atherton, H. C., Nicholls, A., Giddings, J., Sugar, R., Jackson, A., Press, N. J., Brown, Z., Butler, K., and Danahay, H. (2005). Characterization of cigarette smoke-induced inflammatory and mucus hypersecretory changes in rat lung and the role of CXCR2 ligands in mediating this effect. Am. J. Physiol. Lung Cell Mol. Physiol. 288, L514tdthom#x2013; L522.
126. Strieter, R. M., Belperio, J. A., Burdick, M. D., and Keane, M. P. (2005a). CXC chemokines in angiogenesis relevant to chronic fibroprolifera-tion. Curr. Drug Targets Inflamm. Allergy 4, 23-26.
127. Strieter, R. M., Keane, M. P., Bur-dick, M. D., Sakkour, A., Murray, L. A., and Belperio, J. A. (2005b). The role of CXCR2/CXCR2 lig-ands in acute lung injury. Curr. Drug Targets Inflamm. Allergy 4, 299-;303.
128. Sue, R. D., Belperio, J. A., Burdick, M. D., Murray, L. A., Xue, Y. Y., Dy, M. C., Kwon, J. J., Keane, M. P., and Strieter, R. M. (2004). CXCR2 is critical to hyperoxia-induced lung injury. J. Immunol. 172, 3860-3868.
129. Sunahara, R. K., Dessauer, C. W., and Gilman, A. G. (1996). Complexity and diversity of mammalian adeny-lyl cyclases. Annu. Rev. Pharmacol. Toxicol. 36, 461tdthom#x2013;480.
130. Tarzami, S. T., Miao, W., Mani, K., Lopez, L., Factor, S. M., Berman, J. W., and Kitsis, R. N. (2003). Opposing effects mediated by the chemokine receptor CXCR2 on myocardial ischemia-reperfusion injury: recruitment of potentially damaging neutrophils and direct myocardial protection. Circulation 108, 2387-;2392.
131. Tirouvanziam, R., Gernez, Y., Conrad, C. K., Moss, R. B., Schrijver, I., Dunn, C. E., Davies, Z. A., Herzenberg, L. A., and Herzenberg, L. A. (2008). Profound functional and signaling changes in viable inflammatory neu-trophils homing to cystic fibrosis air-ways. Proc. Natl. Acad. Sci. U.S.A. 105, 4335-4339.
132. Traves, S. L., Culpitt, S. V., Russell, R. E., Barnes, P. J., and Donnelly, L. E. (2002). Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD. Thorax 57, 590-595.
133. Traves, S. L., Smith, S. J., Barnes, P. J., and Donnelly, L. E. (2004). Spe-cific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2. J. Leukoc. Biol. 76, 441-450.
134. Tsai, W. C., Strieter, R. M., Mehrad, B., Newstead, M.W., Zeng, X., and Standiford, T. J. (2000). CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aerugi-nosa pneumonia. Infect. Immun. 68, 4289-;4296.
135. Turunen, A. J., Lindgren, L., Salmela, K. T., Kyllonen, L. E., Makisalo, H., Siitonen, S. M., and Peso-nen, E. J. (2004). Association of graft neutrophil sequestration with delayed graft function in clinical renal transplantation. Transplanta-tion 77, 1821-1826.
136. Unger, V. M., and Schertler, G. F. (1995). Low resolution structure of bovine rhodopsin determined by electron cryo-microscopy. Biophys. J. 68, 1776-1786.
137. Van Damme, J., Decock, B., Conings, R., Lenaerts, J. P., Opdenakker, G., and Billiau, A. (1989). The chemo-tactic activity for granulocytes pro-duced by virally infected fibroblasts is identical to monocyte-derived interleukin 8. Eur. J. Immunol. 19, 1189-1194.
138. Varnai, P., Rother, K. I., and Balla, T. (1999). Phosphatidylinositol 3-kinase-dependent membrane asso-ciation of the Brutons tyrosine kinase pleckstrin homology domain visualized in single living cells. J. Biol. Chem. 274, 10983-10989.
139. Virtala, R., Ekman, A. K., Jansson, L., Westin, U., and Cardell, L. O. (2011). Airway inflammation evaluated in a human nasal lipopolysaccharide challenge model by investigating the effect of a CXCR2 inhibitor. Clin. Exp. Allergy 42, 590-596.
140. von Vietinghoff, S., Asagiri, M., Azar, D., Hoffmann, A., and Ley, K. (2010). Defective regulation of CXCR2 facilitates neutrophil release from bone marrow causing spontaneous inflammation in severely NF-kappa B-deficient mice. J. Immunol. 185, 670-678.
141. Voynow, J. A., Fischer, B. M., Malarkey, D. E., Burch, L. H., Wong, T., Long-phre, M., Ho, S. B., and Foster, W. M. (2004). Neutrophil elastase induces mucus cell metaplasia in mouse lung. Am. J. Physiol. Lung Cell Mol. Physiol. 287, L1293tdthom#x2013;L1302.
142. Weiss, S. J. (1989). Tissue destruction by neutrophils. N. Engl. J. Med. 320, 365-376.
143. Welch, H. C., Coadwell, W. J., Ellson, C. D., Ferguson, G. J., Andrews, S. R., Erdjument-Bromage, H., Tempst, P., Hawkins, P. T., and Stephens, L. R. (2002). P-Rex1, a PtdIns(3,4,5)P3-and Gbetagamma-regulated guanine-nucleotide exchange factor for Rac. Cell 108, 809-821.
144. Wettschureck, N., and Offermanns, S. (2005). Mammalian G proteins and their cell type specific functions. Physiol. Rev. 85, 1159-1204.
145. White, J. R., Lee, J. M., Young, P. R., Hertzberg, R. P., Jurewicz, A. J., Chaikin, M. A., Widdowson, K., Foley, J. J., Martin, L. D., Griswold, D. E., and Sarau, H. M. (1998). Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neu-trophil migration. J. Biol. Chem. 273, 10095-10098.
146. Wilkie, T. M., Gilbert, D. J., Olsen, A. S., Chen, X. N., Amatruda, T. T., Koren-berg, J. R., Trask, B. J., de Jong, P., Reed, R. R., and Simon, M. I. (1992). Evolution of the mammalian G pro-tein alpha subunit multigene family. Nat. Genet. 1, 85-;91.
147. Wolf, M., Delgado, M. B., Jones, S. A., Dewald, B., Clark-Lewis, I., and Baggiolini, M. (1998). Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2. Eur. J. Immunol. 28, 164-70.
148. Wu, Y., Wang, S., Farooq, S. M., Castel-vetere, M. P., Hou, Y., Gao, J. L., Navarro, J. V., Oupicky, D., Sun, F., and Li, C. (2012). A chemokine receptor CXCR2 macromolecular complex regulates neutrophil func-tions in inflammatory diseases. J. Biol. Chem. 287, 5744-5755.
149. Yago, T., Shao, B., Miner, J. J., Yao, L., Klopocki, A. G., Maeda, K., Cogge-shall, K. M., and McEver, R. P. (2010). E-selectin engages PSGL-1 and CD44 through a common signaling pathway to induce integrin alphaLbeta2-mediated slow leuko-cyte rolling. Blood 116, 485-494.
150. Zarbock, A., Abram, C. L., Hundt, M., Altman, A., Lowell, C. A., and Ley, K. (2008a). PSGL-1 engagement by E-selectin signals through Src kinase Fgr and ITAM adapters DAP12 and FcR gamma to induce slow leukocyte rolling. J. Exp. Med. 205, 2339-2347
151. Zarbock, A., Allegretti, M., and Ley, K. (2008b). Therapeutic inhibition of CXCR2 by Reparixin attenuates acute lung injury in mice. Br. J. Pharmacol. 155, 357-364.
152. Zarbock, A., Deem, T. L., Burcin, T. L., and Ley, K. (2007a). Gal-phai2 is required for chemokine-induced neutrophil arrest. Blood 110, 3773-3779.
153. Zarbock, A., Lowell, C. A., and Ley, K. (2007b). Spleen tyrosine kinase Syk is necessary for E-selectin-induced alpha(L)beta(2) integrin-mediated rolling on intercellular adhesion molecule-1. Immunity 26, 773-783
154. Zarbock, A., Kempf, T., Wollert, K. C., and Vestweber, D. (2012). Leuko-cyte integrin activation and deacti-vation: novel mechanisms of balanc-ing inflammation. J. Mol. Med. 90, 353-359.
155. Zarbock, A., and Ley, K. (2008). Mechanisms and consequences of neutrophil interaction with the endothelium. Am. J. Pathol. 172, 1-;7.